University of Tennessee Cancer Institute — Memphis, Tennessee

University of Tennessee Cancer Institute is a clinical research site located in Memphis, Tennessee, United States 38103.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute has participated in 49 clinical trials.

Therapeutic areas: Leukemia, Colorectal Cancer, Sickle Cell Anemia.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, Emmaus Medical, Inc..

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute?

University of Tennessee Cancer Institute has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute conducted?

University of Tennessee Cancer Institute has 49 clinical trials on record. Their work covers Leukemia, Colorectal Cancer, Sickle Cell Anemia.

Is University of Tennessee Cancer Institute accredited by Crixeo Health?

Yes — University of Tennessee Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Tennessee Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.